5 November 2025 | 12:23AM HKT Equity Research WuXi XDC (2268.HK): APAC Healthcare Corporate Day 2025 — Key Takeaways: new order momentum continues; on-track to achieve Presenters: We hosted WuXi XDC's head of IR with investors on Nov 4 at our APAC Healthcare Corporate Day 2025. Bottom line: 1) Order momentum remains strong, with robust client demand— particularly from US customers. Exploration beyond ADCs continues to be active, e.g. AOC/RDC, etc. Full-year revenue guidance of +45% y/y is on track, while gr ...